Bionik Laboratories Corp. and Curexo Enter Exclusive Distribution Agreement for Sale of Robotic Rehabilitation Systems in U.S. and South Korea
Agreement further expands Bionik's footprint in Asia though Curexo's sales and distribution network in South Korea; Initial orders for each company's technology to ship in the coming weeks TORONTO and BOSTON, March 7, 2018 -- (Healthcare Sales & Marketi... Devices, Distribution Bionik Laboratories, Curexo, InMotion Robotic Systems (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 7, 2018 Category: Pharmaceuticals Source Type: news

Panther Orthopedics, Inc. Receives FDA 510(k) Clearance for the PUMA System(TM) - An Orthopedic Flexible Fixation Device
TAIPEI, Taiwan, March 7, 2018 -- (Healthcare Sales & Marketing Network) -- Panther Orthopedics, Inc., a San Jose, California medical device company, announces today that the company has received U. S. Food and Drug Administration 510(k) clearance for the ... Devices, Orthopaedic, FDA Panther Orthopedics, PUMA System, flexible fixation, Syndesmosis Fixation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 7, 2018 Category: Pharmaceuticals Source Type: news

Hoth Therapeutics Inc. Announces Completion of Series A Financing And Looks to Broaden Its Product Pipeline
NEW YORK, March 7, 2018 -- (Healthcare Sales & Marketing Network) -- Hoth Therapeutics Inc. ("Hoth" or the "Company"), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from in... Biopharmaceuticals, Dermatology, Venture Capital Hoth Therapeutics, atopic dermatitis, eczema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 7, 2018 Category: Pharmaceuticals Source Type: news

Contego Medical Announces the Start of Enrollment in the PERFORMANCE I Trial
RALEIGH, N.C., March 7, 2018 -- (Healthcare Sales & Marketing Network) -- Contego Medical, LLC has announced the beginning of enrollment in the PERFORMANCE I Trial, a clinical trial designed to evaluate the safety and feasibility of the Neuroguard IEP&reg... Devices, Interventional Cardiology Contego Medical, Neuroguard IEP, 3-in-1 Carotid Stent, Embolic Protection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 7, 2018 Category: Pharmaceuticals Source Type: news

Validic Launches Lightweight Remote Monitoring Platform
At HIMSS18, Validic announces device-agnostic remote monitoring extension to augment functionality of existing clinical and care management systems LAS VEGAS, March 6, 2018 -- (Healthcare Sales & Marketing Network) -- Validic, the leading provider of d... Devices, Monitoring, Product Launch Validic, Validic Impact, remote monitoring (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 6, 2018 Category: Pharmaceuticals Source Type: news

FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes
Test only reports 3 out of more than 1,000 known BRCA mutations and negative result doesn't rule out increased cancer risk SILVER SPRING, Md., March 6, 2018 -- (Healthcare Sales & Marketing Network) -- The U.S. Food and Drug Administration today authori... Diagnostics, Oncology, FDA 23andMe, Genetic Health Risk, BRCA1, BRCA2, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 6, 2018 Category: Pharmaceuticals Source Type: news

New Q-FIX(TM) CURVED, Q-FIX MINI and SUTUREFIX CURVED All-Suture Anchor Systems help surgeons access challenging pathology while improving the quality of shoulder and hip repairs
LONDON, March 6, 2018 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (NYSE: SNN, LSE: SN), the global medical technology business, is pleased to announce the launch of Q-FIX™ CURVED, Q-FIX MINI and SUTUREFIX CURVED All-Suture Anchor systems ... Devices, Orthopaedic, Product Launch Smith & Nephew, Q-FIX, SUTUREFIX (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 6, 2018 Category: Pharmaceuticals Source Type: news

Corin Group Launches Trinity(TM) Dual Mobility System for Hip Replacement at AAOS 2018 Annual Meeting
New Hip Implant Designed for Use with Optimized Positioning System (OPS™) to Improve Stability and Functional Positioning NEW ORLEANS, March 6, 2018 -- (Healthcare Sales & Marketing Network) -- Corin, a global orthopaedic manufacturer and leader in fun... Devices, Orthopaedic, Product Launch Corin Group, Trinity, Dual Mobility System, Hip Replacement (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 6, 2018 Category: Pharmaceuticals Source Type: news

Wendy Sussman Joins EMD Serono as Vice President of U.S. Healthcare Government and Public Affairs
ROCKLAND, Mass., March 6, 2018 -- (Healthcare Sales & Marketing Network) -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, today announced that Wendy Sussman has joined the organization as Vice Preside... Biopharmaceuticals, Personnel EMD Serono, Merck KGaA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 6, 2018 Category: Pharmaceuticals Source Type: news

Stryker Launches Next Generation Trident(R) II Acetabular System
System features Trident II Tritanium, building on Trident brand legacy, combining the reproducibility of AMagine™ additive manufactured Tritanium® In-Growth Technology with the precision of Mako Robotic-Arm Assisted Surgery[1] MAHWAH, N.J., March 6... Devices, Orthopaedic, Product Launch Stryker, Trident, Acetabular System, hip replacement (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 6, 2018 Category: Pharmaceuticals Source Type: news

Smith and Nephew announces full commercial release of JOURNEY(TM) II XR Total Knee Arthroplasty
LONDON, March 6, 2018 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (LSE:SN, NYSE: SNN), the global medical technology business, today announces the full commercial release of bi-cruciate retaining JOURNEY II XR total knee arthroplasty (TKA)... Devices, Orthopaedic, Product Launch Smith & Nephew, JOURNEY II XR, total knee arthroplasty (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 6, 2018 Category: Pharmaceuticals Source Type: news

U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
NDA acceptance of prucalopride reinforces Shire's long-standing heritage in gastrointestinal (GI) conditions and deep in-house capabilities in the category If approved, prucalopride will be the only readily available 5-HT4 agonist[1] in the U.S. for chr... Biopharmaceuticals, Gastroenterology, FDA Shire, Prucalopride, Chronic Idiopathic Constipation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 5, 2018 Category: Pharmaceuticals Source Type: news

Philips introduces next generation of IntelliSpace Cardiovascular informatics platform at HIMSS 2018
Comprehensive informatics and imaging solution features enhanced security protocols to meet industry-leading standards Improved interoperability and standardization increases scalability across the hospital enterprise to help improve efficiency and qual... Devices, Cardiology, Product Launch Royal Philips, IntelliSpace Cardiovascular, imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 5, 2018 Category: Pharmaceuticals Source Type: news

A Connected Wearable Device to Help People Get to the Bathroom Before It's Too Late to Be Released in US Later This Year
SAN DIEGO, March 5, 2018 -- (Healthcare Sales & Marketing Network) -- Triple W, a startup company that develops the first connected wearable device that can track the progression of bladder movements using non-invasive ultrasonic sensors, announced today ... Devices, Urology, Monitoring, Product Launch Triple W, incontinence (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 5, 2018 Category: Pharmaceuticals Source Type: news

Aridis Pharmaceuticals, Inc. Appoints Wolfgang Dummer, M.D., Ph.D., as Chief Medical Officer, and Mitchell H. Rosner, Ph.D. as Vice President of Quality
SAN JOSE, Calif., March 5, 2018 -- (Healthcare Sales & Marketing Network) -- Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies for infectious diseases, has appo... Biopharmaceuticals, Oncology, Personnel Aridis Pharmaceuticals, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 5, 2018 Category: Pharmaceuticals Source Type: news

Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
DUBLIN, March 2, 2018 -- (Healthcare Sales & Marketing Network) -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with standard review the company's New Drug Application (ND... Biopharmaceuticals, FDA Jazz Pharmaceuticals, solriamfetol, narcolepsy, obstructive sleep apnea (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 2, 2018 Category: Pharmaceuticals Source Type: news

Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.
FDA recently approved Symfi Lo™, a three-drug single-tablet antiretroviral (ARV) regimen, and Cimduo™, a double combination, for HIV treatment Mylan will launch Symfi Lo and Cimduo at a significant discount to the price of competing products to bring co... Biopharmaceuticals, HIV/AIDS, Product Launch Mylan, Symfi Lo, Cimduo, efavirenz, lamivudine, tenofovir (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 2, 2018 Category: Pharmaceuticals Source Type: news

Philips and Hologic announce global partnership agreement to provide integrated imaging solutions for women's health
Partnership will allow hospitals easier access to integrated suites of diagnostic imaging modalities, advanced informatics and services for comprehensive breast screening and diagnosis AMSTERDAM and MARLBOROUGH, Mass., March 2, 2018 -- (Healthcare Sales... Devices, Radiology Hologic, Royal Philips, mammography, ultrasound, MRI, imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 2, 2018 Category: Pharmaceuticals Source Type: news

CARsgen Completed $60 Million Pre-C Financing Framework Agreements
SHANGHAI, March 2, 2018 -- (Healthcare Sales & Marketing Network) -- CARsgen Therapeutics, a leading immune-oncology company focusing on the development of CAR-T therapies, today announces it has entered into a Pre-C financing framework agreement with rec... Biopharmaceuticals, Oncology, Venture Capital CARsgen Therapeutics, CAR-T therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 2, 2018 Category: Pharmaceuticals Source Type: news

FDA to Review DUPIXENT(R) (dupilumab) as Potential Treatment for Moderate-to-Severe Asthma
TARRYTOWN, N.Y. and PARIS, March 2, 2018 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biolo... Biopharmaceuticals, FDA Regeneron Pharmaceuticals, Sanofi, DUPIXENT, dupilumab, asthma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 2, 2018 Category: Pharmaceuticals Source Type: news

Breathtec Biomedical Announces Appointment of CEO
VANCOUVER, British Columbia, March 01, 2018 -- (Healthcare Sales & Marketing Network) -- Breathtec Biomedical Inc. (CSE:BTH) (CNSX:BTH) (FRANKFURT:BTI) (OTCQB:BTHCF) (the “Company”) is pleased to announce the appointment of Christopher J. Moreau as Chief E... Devices, Personnel Breathtec Biomedical, airborne analysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 1, 2018 Category: Pharmaceuticals Source Type: news

Vital Images(R) Launches Vitrea(R) Connection Version 7.0 at HIMSS 2018
MINNETONKA, Minn., March 01, 2018 -- (Healthcare Sales & Marketing Network) -- Vital Images is pleased to announce the release of Vitrea Connection version 7.0 with new features that take its enterprise imaging solution to the next level of innovation by i... Devices, Radiology, Product Launch Vital Images, Vitrea Connection, imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 1, 2018 Category: Pharmaceuticals Source Type: news

SUBLOCADE(TM) (Buprenorphine Extended-Release) is Now Available as First and Only Monthly Injectable Buprenorphine in the U.S. to Treat Patients with Moderate to Severe Opioid Use Disorder
Indivior launches new support services dedicated to helping streamline the access process on behalf of patients SLOUGH, England and RICHMOND, Va., March 1, 2018 -- (Healthcare Sales & Marketing Network) -- Indivior PLC (LON: INDV) today announced that ... Biopharmaceuticals, FDA, Product Launch Indivior, SUBLOCADE, buprenorphine, opioid use disorder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 1, 2018 Category: Pharmaceuticals Source Type: news

Successful First in Human for OrthoSpin's Robotic External Orthopedic Fixation System
MISGAV, Israel, Feb. 28, 2018 -- (Healthcare Sales & Marketing Network) -- OrthoSpin Ltd. ("OrthoSpin"), a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T; OTCQX: TRNLY), announced that it successfully completed... Devices, Orthopaedic OrthoSpin, robotic external fixation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 28, 2018 Category: Pharmaceuticals Source Type: news

Metabolon Launches Meta UDx(TM) Test to Speed Diagnosis of Rare and Undiagnosed Diseases in Children and Adults
Meta UDx provides in-depth metabolic information and new insights for difficult-to-diagnose patient cases Expanding LDT clinical testing portfolio demonstrates value of clinical metabolomics for rare and undiagnosed diseases RESEARCH TRIANGLE PARK, N... Diagnostics, Product Launch Metabolon, Meta UDx (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 28, 2018 Category: Pharmaceuticals Source Type: news

Poseida Therapeutics Appoints Mark Gergen as Chief Business Officer and Chief Financial Officer
SAN DIEGO, Feb. 28, 2018 -- (Healthcare Sales & Marketing Network) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced that Mark J. Gerg... Biopharmaceuticals, Oncology, Personnel Poseida Therapeutics, CAR T-cell, immunotherapy, multiple myeloma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 28, 2018 Category: Pharmaceuticals Source Type: news

Invuity Announces Changes to Executive Leadership Team
Scott D. Flora appointed Interim President and Chief Executive Officer Philip Sawyer steps down as President and Chief Executive Officer SAN FRANCISCO, Feb. 28, 2018 -- (Healthcare Sales & Marketing Network) -- Invuity, Inc. (NASDAQ:IVTY), a leading ... Devices, Surgery, Personnel Invuity, Intelligent Photonics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 28, 2018 Category: Pharmaceuticals Source Type: news

SnoreRx, Now Available at CVS, is First and Only FDA Certified Non-prescription Anti Snoring Treatment
ALISO VIEJO, Calif., Feb. 28, 2018 -- (Healthcare Sales & Marketing Network) -- Apnea Sciences Corporation announced that SnoreRx is now available at selected CVS pharmacies. FDA has recently cleared SnoreRx as the first and only oral appliance for the tr... Devices, Product Launch SnoreRx, snoring (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 28, 2018 Category: Pharmaceuticals Source Type: news

VitalConnect Launches Continuous Patient Monitoring Platform in Hospitals Nationwide
Company unveils at HIMSS 2018; Mercy hospitals first to roll out SAN JOSE, Calif., Feb. 27, 2018 -- (Healthcare Sales & Marketing Network) -- VitalConnect®, Inc., a leader in wearable biosensor technology for wireless monitoring in hospitals and re... Devices, Monitoring, Product Launch VitalConnect, Vista Solution, VitalPatch (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 27, 2018 Category: Pharmaceuticals Source Type: news

Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta(R) (pegfilgrastim)
Innovative Neulasta® Onpro® Kit is Designed to Provide the Right Dose for Patients at the Right Time THOUSAND OAKS, Calif., Feb. 27, 2018 -- (Healthcare Sales & Marketing Network) -- Amgen (NASDAQ: AMGN) today announced that the Committee for M... Biopharmaceuticals, Drug Delivery, Regulatory Amgen, Neulasta, pegfilgrastim, Neulasta Onpro Kit, neutropenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 27, 2018 Category: Pharmaceuticals Source Type: news

Abbott and Surmodics Announce Agreement for Next-Generation Drug-Coated Balloon
COMPANIES TO COLLABORATE ON PRODUCT DEVELOPMENT, CLINICAL TRIALS AND REGULATORY ACTIVITIES TO OBTAIN APPROVAL IN U.S. AND E.U. AGREEMENT COMPLEMENTS AND EXTENDS ABBOTT'S BROAD LINE OF VASCULAR CARE PRODUCTS AND DEMONSTRATES VALUE OF SURMODICS' PROPRIETA... Devices, Interventional, Licensing Abbott, Surmodics, Drug-Coated Balloon, SurVeil, peripheral artery disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 27, 2018 Category: Pharmaceuticals Source Type: news

BIOLASE Announces Memorandum Of Understanding With S-Ray To Market, Sell Disruptive Radiation-Free Dental Imaging Device
Innovative ClearView SCAN™ Device: Dentistry's First Intra-oral Ultrasound Diagnostic Imaging IRVINE, Calif., Feb. 27, 2018 -- (Healthcare Sales & Marketing Network) -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced t... Devices, Dental BIOLASE, S-Ray, ClearView SCAN, intraoral imaging system (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 27, 2018 Category: Pharmaceuticals Source Type: news

Senti Biosciences Secures $53 Million Series A to Build the Future of Gene and Cell-Based Therapies
Founded by pioneers in the field of synthetic biology, Senti Biosciences' platform enables the design of adaptive therapies for challenging diseases. Series A round led by prominent investment firm New Enterprise Associates (NEA) along with other top inves... Biopharmaceuticals, Venture Capital Senti Biosciences, synthetic biology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 27, 2018 Category: Pharmaceuticals Source Type: news

Elekta Collaborates With Leading New York Cancer Center to Continue Development of Clinical Protocols for MR-linac Technology
STOCKHOLM, Feb. 27, 2018 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) has entered into a research agreement with Memorial Sloan Kettering Cancer Center (MSK), a world leader in patient care, research and education programs, located in N... Devices, Oncology Elekta, MR-linac, radiation therapy, MR/RT, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 27, 2018 Category: Pharmaceuticals Source Type: news

Integra LifeSciences Appoints Sravan Emany as Vice President, Treasurer and Investor Relations
PLAINSBORO, N.J., Feb. 26, 2018 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the appointment of Sravan Emany as vice president, treasurer and investor relations. Mr. Emany will be a m... Devices, Orthopaedic, Surgery, Personnel Integra LifeSciences (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 26, 2018 Category: Pharmaceuticals Source Type: news

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels
FDA Approved, Resolute Onyx 2.0 mm DES Technology Tackles Clinical Challenge of Treating Coronary Artery Disease in Previously Untreatable Patients DUBLIN - February 26, 2018 - Designed specifically for small vessels, Medtronic plc (NYSE: MDT) today ann... Devices, Interventional, Cardiology, Product Launch Medtronic, Resolute Onyx, Drug-Eluting Stent (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 26, 2018 Category: Pharmaceuticals Source Type: news

GigaGen Announces Appointment of Jan Fredrik Simons, Ph.D., as Senior Director, Technology
Dr. Simons will lead development of custom sequencing technology for antibody screening and immune function analysis SOUTH SAN FRANCISCO, Calif., Feb. 26, 2018 -- (Healthcare Sales & Marketing Network) -- GigaGen Inc., a biopharmaceutical company deve... Biopharmaceuticals, Oncology, Personnel GigaGen, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 26, 2018 Category: Pharmaceuticals Source Type: news

Check-Cap Appoints Alex Ovadia as Chief Executive Officer
Global Operations and R&D Veteran Brings Focus to C-Scan® Commercial Pathway ISFIYA, Israel, Feb. 26, 2018 -- (Healthcare Sales & Marketing Network) -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clini... Devices, Gastroenterology, Personnel Check-Cap, C-Scan, capsule, colorectal cancer, colonoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 26, 2018 Category: Pharmaceuticals Source Type: news

Genomic Health Expands Offering to Prostate Cancer Patients with Launch of Oncotype DX(R) AR-V7 Nucleus Detect(TM) Test to Predict Treatment Response in Metastatic Disease
New Liquid Biopsy Test Helps Physicians Select Most Effective Treatment, Prolonging Lives of Men with Metastatic Castration-resistant Prostate Cancer REDWOOD CITY, Calif., Feb. 26, 2018 -- (Healthcare Sales & Marketing Network) -- Genomic Health, Inc. ... Diagnostics, Oncology, Product Launch Genomic Health, Oncotype DX, AR-V7 Nucleus Detect, liquid biopsy, mCRPC (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 26, 2018 Category: Pharmaceuticals Source Type: news

Multicenter Study(1) Suggests Hill-Rom MetaNeb(R) System Reduces Incidence of Post-Operative Pulmonary Complications in High-Risk Patients
CHICAGO, Feb. 26, 2018 -- (Healthcare Sales & Marketing Network) -- A group of researchers have reported that aggressive treatment after surgery using the Hill-Rom MetaNeb® System may reduce the incidence of post-operative pulmonary complications (PPC... Devices Hill-Rom, MetaNeb System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 26, 2018 Category: Pharmaceuticals Source Type: news

New Data Show Lilly's Trulicity(R) (dulaglutide) in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes
INDIANAPOLIS, Feb. 26, 2018 -- (Healthcare Sales & Marketing Network) -- Trulicity® (dulaglutide) significantly improves A1C (average blood sugar concentration over two to three months) when added to ongoing treatment with a sodium-glucose co-transpor... Biopharmaceuticals, Endocrinology Eli Lilly, Trulicity, dulaglutide, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 26, 2018 Category: Pharmaceuticals Source Type: news

Kazia Receives FDA Orphan Designation for GDC-0084
SYDNEY, Feb. 23, 2018 -- (Healthcare Sales & Marketing Network) -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) ... Biopharmaceuticals, Oncology, FDA Kazia Therapeutics, GDC-0084, glioblastoma multiforme (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 23, 2018 Category: Pharmaceuticals Source Type: news

VoCare Develops the World's First Mobile Professional Grade Medical Multi-Diagnostic Device, Which Provides a Revolutionary Integrated Mobile Point-of-Care Solution as Well as a Remote Patient Monitoring Solution
INDIANAPOLIS, Feb. 23, 2018 -- (Healthcare Sales & Marketing Network) -- VoCare, Inc., an Indiana-based company, has developed the world's first professional grade medical diagnostic device which collects 6 different health vitals and is equipped with WiF... Devices, Monitoring VoCare, Vitals360 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 23, 2018 Category: Pharmaceuticals Source Type: news

Amgen Receives Positive Opinion Expanding Use Of XGEVA(R) (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe
Application Based on Data From Largest International Multiple Myeloma Trial for the Prevention of Skeletal-Related Events Ever Conducted THOUSAND OAKS, Calif., Feb. 23, 2018 -- (Healthcare Sales & Marketing Network) -- Amgen (NASDAQ: AMGN) today announ... Biopharmaceuticals, Oncology, Regulatory Amgen, XGEVA, denosumab, Multiple Myeloma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 23, 2018 Category: Pharmaceuticals Source Type: news

Getinge announces U.S. Food and Drug Administration 510(k) clearance for PulsioFlex Monitoring System and PiCCO Module
Getinge plans to launch advanced patient monitoring system and accompanying hemodynamic monitoring technology in the United States during the first quarter of 2018 for use with critically ill patients WAYNE, N.J, Feb. 23, 2018 -- (Healthcare Sales & Mar... Devices, Monitoring, FDA Getinge, Maquet, PulsioFlex, PiCCO Module (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 23, 2018 Category: Pharmaceuticals Source Type: news

Vascular Graft Solutions: External Stenting of Vein Grafts is Associated With High Early Patency Rates
Interim report from the post-marketing randomized VEST III trial TEL AVIV, Israel, Feb. 23, 2018 -- (Healthcare Sales & Marketing Network) -- Vascular Grafts Solutions announced today the interim results from the VEST III study, a post-marketing trial ... Devices, Cardiology Vascular Grafts Solutions, Venous External SupporT (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 23, 2018 Category: Pharmaceuticals Source Type: news

Mallinckrodt Receives FDA Acceptance of Stannsoporfin New Drug Application Filing
Action date set for August 22, 2018 STAINES-UPON-THAMES, United Kingdom, Feb. 23, 2018 -- (Healthcare Sales & Marketing Network) -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced the U.S. Food and Drug ... Biopharmaceuticals, FDA Mallinckrodt, stannsoporfin, hyperbilirubinemia, jaundice (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 23, 2018 Category: Pharmaceuticals Source Type: news

GenomeDx Announces Inclusion of Decipher Genomic Testing in NCCN Guidelines for Prostate Cancer
Decipher testing recognized as standard-of-care in management of prostate cancer patients SAN DIEGO, Feb. 22, 2018 -- (Healthcare Sales & Marketing Network) -- GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced tha... Diagnostics, Oncology GenomeDx Biosciences, NCCN, Decipher Prostate, Prostate Cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 22, 2018 Category: Pharmaceuticals Source Type: news

NN, Inc. Announces The Acquisition Of Bridgemedica, LLC
JOHNSON CITY, Tenn., Feb. 22, 2018 -- (Healthcare Sales & Marketing Network) -- NN, Inc., (NASDAQ: NNBR) a diversified industrial company, today announced it has completed the acquisition of the assets of Bridgemedica, LLC ("Bridgemedica"), a me... Devices, Mergers & Acquisitions NN , Bridgemedica (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 22, 2018 Category: Pharmaceuticals Source Type: news

Access Vascular Receives FDA Clearance For Its HydroPICC Catheter
The HydroPICC Uses Proprietary Technology Designed to Reduce Thrombosis BEDFORD, Mass., Feb. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Access Vascular, a medical device company reinventing venous access using proprietary material technology... Devices, FDA Access Vascular, HydroPICC, peripherally inserted central catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 22, 2018 Category: Pharmaceuticals Source Type: news